x
Filter:
Filters applied
- EMAS Position Statements and Clinical Guides
- Anagnostis, PanagiotisRemove Anagnostis, Panagiotis filter
- Senturk, Levent MRemove Senturk, Levent M filter
- 2017 - 2022Remove 2017 - 2022 filter
Author
- Cano, Antonio1
- Chedraui, Peter1
- Goulis, Dimitrios G1
- Jaremek, Jesse D1
- Lambrinoudaki, Irene1
- Lopes, Patrice1
- Meczekalski, Blazej1
- Mishra, Gita1
- Mueck, Alfred1
- Paschou, Stavroula A1
- Rees, Margaret1
- Rogowicz-Frontczak, Anita1
- Simoncini, Tommaso1
- Slopien, Radoslaw1
- Stevenson, John C1
- Stute, Petra1
- Tuomikoski, Pauliina1
- Wender-Ozegowska, Ewa1
- Zozulinska-Ziolkiewicz, Dorota1
EMAS Position Statements and Clincial Guides
1 Results
- Research Article
Menopause and diabetes: EMAS clinical guide
MaturitasVol. 117p6–10Published online: August 22, 2018- Radoslaw Slopien
- Ewa Wender-Ozegowska
- Anita Rogowicz-Frontczak
- Blazej Meczekalski
- Dorota Zozulinska-Ziolkiewicz
- Jesse D. Jaremek
- and others
Cited in Scopus: 65Diabetes mellitus (DM) is a public health problem, especially in developed countries. It affects about 9.1% of the adult population in Europe and 13.3% in the United States of America [1]. The greater prevalence of DM in developed countries is broadly associated with ageing of the population [2]. Between 2015 and 2030, the world population aged over 60 years is projected to increase by 56%, from 901 million to 1.4 billion; by 2050 it is expected to reach nearly 2.1 billion [3]. These data suggest that the number of postmenopausal women with DM will grow substantially.
